Harris, Jennifer Leslie,Li, Nanxin,Smith, Timothy R.
申请号：
AU2018236813
公开号：
AU2018236813A1
申请日:
2018.09.27
申请国别(地区):
AU
年份:
2018
代理人:
摘要：
#$%^&*AU2018236813A120181018.pdf#####C: Interwovn NRPortbl DCC SXD 17775423_l.docx-26 09 2018 ABSTRACT The present invention relates to a pharmaceutical combination comprising, separately or together, (1) a first agent which is an ALK inhibitor or a pharmaceutically acceptable salt thereof and (2) a second agent which is a CDK inhibitor or a pharmaceutically acceptable salt thereof. The invention further relates the use of such combination in the treatment or prevention of proliferative diseases.WO 2015/031666 PCT/US2014/053244 27/38 41!A!I!PPV Qj*=uoilqqul E 0 (f) 0 C, [V punodwoo ~~ZI= CNL C U-) Lr) *O P - O e-J U r u-i C~ qd- '- w - r- M~ to Ul Ul 00 C-4 e) rn te) re) C o I) 00 '4- to - t r- ' Md U- ) C I -I I rn V')~~~r C>；0JU ,0 re) _NC c~~~c r- c O O-~0 . - C1 C I 7 I ' 21 4 IQ CO 10 (lrd) LV punodwoo
